BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X, Li Z, Yi Z, Geng D. Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology 2020;114:104595. [DOI: 10.1016/j.psyneuen.2020.104595] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Ma N, Wang R. Mendelian randomization study on the effect of tumor necrosis factor on schizophrenia. Psychiatric Genetics 2022;32:238-245. [DOI: 10.1097/ypg.0000000000000329] [Reference Citation Analysis]
2 Ahmad S, Azhar A, Tikmani P, Rafique H, Khan A, Mesiya H, Saeed H. A randomized clinical trial to test efficacy of chamomile and saffron for neuroprotective and anti-inflammatory responses in depressive patients. Heliyon 2022;8:e10774. [DOI: 10.1016/j.heliyon.2022.e10774] [Reference Citation Analysis]
3 Dudzińska E, Szymona K, Bogucki J, Koch W, Cholewińska E, Sitarz R, Ognik K. Increased Markers of Oxidative Stress and Positive Correlation Low-Grade Inflammation with Positive Symptoms in the First Episode of Schizophrenia in Drug-Naïve Patients. J Clin Med 2022;11:2551. [PMID: 35566680 DOI: 10.3390/jcm11092551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu Z, Gao J, Ye X, Wang C, Zhao B, Song L. Endogenous Sulfur Dioxide Improves the Survival Rate of Sepsis by Improving the Oxidative Stress Response during Lung Injury. Oxidative Medicine and Cellular Longevity 2022;2022:1-9. [DOI: 10.1155/2022/6339355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
6 Juchnowicz D, Dzikowski M, Rog J, Waszkiewicz N, Zalewska A, Maciejczyk M, Karakuła-Juchnowicz H. Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia. Front Psychiatry 2021;12:728986. [PMID: 34867519 DOI: 10.3389/fpsyt.2021.728986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Goh XX, Tang PY, Tee SF. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis. Asian J Psychiatr 2021;67:102932. [PMID: 34839098 DOI: 10.1016/j.ajp.2021.102932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kim E, Zhao Z, Rzasa JR, Glassman M, Bentley WE, Chen S, Kelly DL, Payne GF. Association of acute psychosocial stress with oxidative stress: Evidence from serum analysis. Redox Biol 2021;47:102138. [PMID: 34555595 DOI: 10.1016/j.redox.2021.102138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zhu M, Liu Z, Guo Y, Sultana MS, Wu K, Lang X, Lv Q, Huang X, Yi Z, Li Z. Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. J Neuroinflammation 2021;18:202. [PMID: 34526062 DOI: 10.1186/s12974-021-02261-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Ferreira Antunes Neto JM, Nalesso AM. CHANGES IN OXIDATIVE STRESS BIOMARKERS IN THE FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. int jour sci res mana 2021;9:440-451. [DOI: 10.18535/ijsrm/v9i09.mp01] [Reference Citation Analysis]
11 Li Z, Liu X, Xu H, Zhao L, Zhou Y, Wu X, Huang X, Lang X, Wu F, Zhang X. Sex Difference in Comorbid Depression in First-Episode and Drug-Naive Patients With Schizophrenia: Baseline Results From the Depression in Schizophrenia in China Study. Psychosom Med 2021;83:1082-8. [PMID: 34419998 DOI: 10.1097/PSY.0000000000000998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Shen H, Zhang L, Li Y, Zheng D, Du L, Xu F, Xu C, Liu Y, Shen J, Li Z, Cui D. Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study. Psychol Med . [DOI: 10.1017/s0033291721002944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li Z, Xue M, Zhao L, Zhou Y, Wu X, Xie X, Lang X, Zhang X. Comorbid major depression in first-episode drug-naïve patients with schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study. J Affect Disord 2021;294:33-8. [PMID: 34265669 DOI: 10.1016/j.jad.2021.06.075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lang X, Zhou Y, Zhao L, Gu Y, Wu X, Zhao Y, Li Z, Zhang X. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients. Psychoneuroendocrinology 2021;132:105344. [PMID: 34274733 DOI: 10.1016/j.psyneuen.2021.105344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li Z, Wang S, Chen Y, Wu X, Gu Y, Lang X, Wu F, Zhang XY. Smoking affects the patterns of metabolic disorders and metabolic syndrome in patients with first-episode drug-naive schizophrenia - a large sample study based on Chinese Han population. Int J Neuropsychopharmacol 2021:pyab038. [PMID: 34153098 DOI: 10.1093/ijnp/pyab038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
16 Li Z, Ruan M, Chen J, Fang Y. Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications. Neurosci Bull 2021;37:863-80. [PMID: 33582959 DOI: 10.1007/s12264-021-00638-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 37.0] [Reference Citation Analysis]
17 Huang X, Bao C, Lv Q, Zhao J, Hu G, Wu H, Li Z, Yi Z. MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study. J Psychopharmacol 2021;35:23-30. [PMID: 33274684 DOI: 10.1177/0269881120959617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Moossavi M, Alaei M, Mohammadoo-khorasani M, Shojaee M, Khorasani M. The polymorphism of TNFα (rs1799964) gene and schizophrenia risk: A meta-analysis. Meta Gene 2020;26:100801. [DOI: 10.1016/j.mgene.2020.100801] [Reference Citation Analysis]
19 Zhou Y, Song X, Guo Y, Lang X, Li Z, Zhang XY. Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. Psychoneuroendocrinology 2021;124:105061. [PMID: 33291004 DOI: 10.1016/j.psyneuen.2020.105061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
20 Liu W, Fang Y, Shi Y, Cheng Y, Sun C, Cui D. The interaction of histone modification related H3F3B and NSD2 genes increases the susceptibility to schizophrenia in a Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 2020;101:109918. [PMID: 32169559 DOI: 10.1016/j.pnpbp.2020.109918] [Reference Citation Analysis]
21 Su Y, Yang L, Li Z, Wang W, Xing M, Fang Y, Cheng Y, Lin GN, Cui D. The interaction of ASAH1 and NGF gene involving in neurotrophin signaling pathway contributes to schizophrenia susceptibility and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110015. [PMID: 32569620 DOI: 10.1016/j.pnpbp.2020.110015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
22 Huang X, Bao C, Lv Q, Zhao J, Wang Y, Lang X, Li Z, Yi Z. Sex difference in cognitive impairment in drug-free schizophrenia: Association with miR-195 levels. Psychoneuroendocrinology 2020;119:104748. [PMID: 32559610 DOI: 10.1016/j.psyneuen.2020.104748] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]